Rafael Malgor
Concepts (341)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endovascular Procedures | 25 | 2026 | 389 | 6.850 |
Why?
| | Vascular Surgical Procedures | 22 | 2026 | 343 | 4.950 |
Why?
| | Blood Vessel Prosthesis Implantation | 16 | 2025 | 228 | 3.470 |
Why?
| | Venous Thrombosis | 11 | 2026 | 195 | 3.130 |
Why?
| | Aortic Aneurysm, Abdominal | 10 | 2025 | 167 | 2.800 |
Why?
| | Angioplasty, Balloon | 6 | 2023 | 94 | 2.790 |
Why?
| | Stents | 15 | 2024 | 561 | 2.780 |
Why?
| | Varicose Veins | 6 | 2024 | 16 | 2.260 |
Why?
| | Upper Extremity | 4 | 2026 | 113 | 2.210 |
Why?
| | Vena Cava, Inferior | 7 | 2026 | 82 | 2.150 |
Why?
| | Vascular System Injuries | 9 | 2026 | 80 | 2.150 |
Why?
| | Surgeons | 7 | 2025 | 340 | 1.970 |
Why?
| | Carotid Stenosis | 5 | 2024 | 106 | 1.930 |
Why?
| | Venous Insufficiency | 6 | 2024 | 12 | 1.900 |
Why?
| | Vena Cava Filters | 5 | 2024 | 64 | 1.850 |
Why?
| | Aorta, Thoracic | 8 | 2026 | 286 | 1.800 |
Why?
| | Pulmonary Embolism | 5 | 2024 | 241 | 1.780 |
Why?
| | Wounds, Nonpenetrating | 9 | 2026 | 321 | 1.740 |
Why?
| | Treatment Outcome | 50 | 2026 | 11741 | 1.720 |
Why?
| | Femoral Artery | 4 | 2023 | 190 | 1.700 |
Why?
| | Veins | 5 | 2017 | 69 | 1.630 |
Why?
| | Aortic Aneurysm | 3 | 2022 | 70 | 1.620 |
Why?
| | Thoracic Injuries | 6 | 2026 | 71 | 1.570 |
Why?
| | Peripheral Arterial Disease | 6 | 2023 | 506 | 1.560 |
Why?
| | Blood Vessel Prosthesis | 10 | 2024 | 140 | 1.500 |
Why?
| | Popliteal Artery | 3 | 2023 | 62 | 1.480 |
Why?
| | Ultrasonography, Doppler, Duplex | 9 | 2017 | 40 | 1.440 |
Why?
| | Ischemia | 7 | 2021 | 422 | 1.400 |
Why?
| | Anticoagulants | 8 | 2026 | 748 | 1.390 |
Why?
| | Intermittent Claudication | 3 | 2021 | 122 | 1.380 |
Why?
| | Venous Thromboembolism | 6 | 2022 | 328 | 1.360 |
Why?
| | Laser Therapy | 4 | 2022 | 142 | 1.220 |
Why?
| | Saphenous Vein | 5 | 2022 | 37 | 1.160 |
Why?
| | Vascular Patency | 11 | 2026 | 121 | 1.150 |
Why?
| | Endarterectomy, Carotid | 2 | 2024 | 63 | 1.090 |
Why?
| | Aorta, Abdominal | 2 | 2025 | 52 | 1.050 |
Why?
| | Lower Extremity | 6 | 2025 | 440 | 1.040 |
Why?
| | Upper Extremity Deep Vein Thrombosis | 1 | 2026 | 3 | 0.950 |
Why?
| | Catheter Ablation | 3 | 2022 | 355 | 0.930 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 2025 | 17 | 0.930 |
Why?
| | Risk Factors | 26 | 2026 | 10857 | 0.910 |
Why?
| | Doxycycline | 1 | 2025 | 62 | 0.900 |
Why?
| | Thrombectomy | 1 | 2026 | 78 | 0.900 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2025 | 130 | 0.880 |
Why?
| | Arteriovenous Shunt, Surgical | 2 | 2017 | 20 | 0.870 |
Why?
| | Humans | 97 | 2026 | 145140 | 0.870 |
Why?
| | Atherectomy | 2 | 2023 | 37 | 0.870 |
Why?
| | Iliac Aneurysm | 2 | 2022 | 19 | 0.860 |
Why?
| | Prosthesis Design | 10 | 2024 | 354 | 0.860 |
Why?
| | Time Factors | 24 | 2026 | 7107 | 0.840 |
Why?
| | Fibrinolytic Agents | 3 | 2020 | 297 | 0.840 |
Why?
| | Inflammation Mediators | 2 | 2025 | 506 | 0.820 |
Why?
| | Health Care Costs | 2 | 2025 | 425 | 0.800 |
Why?
| | Cranial Nerve Injuries | 1 | 2023 | 5 | 0.770 |
Why?
| | Carotid Body Tumor | 1 | 2023 | 5 | 0.770 |
Why?
| | Mesenteric Vascular Occlusion | 3 | 2011 | 5 | 0.760 |
Why?
| | Aged | 35 | 2026 | 26096 | 0.760 |
Why?
| | Aged, 80 and over | 18 | 2024 | 8318 | 0.750 |
Why?
| | Embolic Protection Devices | 1 | 2022 | 12 | 0.740 |
Why?
| | Vascular Diseases | 3 | 2015 | 252 | 0.730 |
Why?
| | Aortic Aneurysm, Thoracic | 3 | 2024 | 138 | 0.710 |
Why?
| | Anti-Inflammatory Agents | 1 | 2025 | 477 | 0.710 |
Why?
| | Intestinal Perforation | 2 | 2012 | 46 | 0.700 |
Why?
| | Duodenum | 2 | 2012 | 77 | 0.690 |
Why?
| | Practice Patterns, Physicians' | 4 | 2020 | 1365 | 0.680 |
Why?
| | Coated Materials, Biocompatible | 1 | 2021 | 65 | 0.660 |
Why?
| | Vascular Calcification | 2 | 2020 | 110 | 0.660 |
Why?
| | Renal Dialysis | 2 | 2017 | 466 | 0.650 |
Why?
| | Retrospective Studies | 22 | 2026 | 17247 | 0.650 |
Why?
| | Angioplasty | 3 | 2012 | 50 | 0.650 |
Why?
| | Platelet Aggregation Inhibitors | 2 | 2021 | 499 | 0.630 |
Why?
| | Male | 47 | 2026 | 72664 | 0.620 |
Why?
| | Lithotripsy | 1 | 2020 | 49 | 0.610 |
Why?
| | Middle Aged | 34 | 2026 | 36126 | 0.610 |
Why?
| | Female | 53 | 2026 | 78636 | 0.610 |
Why?
| | Leg | 3 | 2021 | 242 | 0.600 |
Why?
| | Plaque, Atherosclerotic | 1 | 2020 | 61 | 0.600 |
Why?
| | Benchmarking | 1 | 2021 | 188 | 0.600 |
Why?
| | Aorta | 2 | 2012 | 439 | 0.590 |
Why?
| | Risk Adjustment | 1 | 2019 | 85 | 0.580 |
Why?
| | Watchful Waiting | 1 | 2019 | 90 | 0.570 |
Why?
| | Postoperative Complications | 12 | 2025 | 2961 | 0.540 |
Why?
| | Iliac Artery | 2 | 2022 | 55 | 0.520 |
Why?
| | Atherosclerosis | 1 | 2021 | 409 | 0.510 |
Why?
| | Prosthesis Failure | 3 | 2019 | 125 | 0.510 |
Why?
| | Surgical Stapling | 1 | 2017 | 15 | 0.510 |
Why?
| | Vascular Malformations | 2 | 2015 | 52 | 0.500 |
Why?
| | Thoracoscopy | 1 | 2017 | 60 | 0.500 |
Why?
| | Aneurysm | 1 | 2017 | 37 | 0.500 |
Why?
| | Sclerotherapy | 3 | 2024 | 19 | 0.490 |
Why?
| | Medicare | 1 | 2022 | 902 | 0.470 |
Why?
| | Hand | 1 | 2017 | 157 | 0.460 |
Why?
| | Brachial Artery | 1 | 2017 | 208 | 0.460 |
Why?
| | Peripheral Vascular Diseases | 2 | 2013 | 104 | 0.450 |
Why?
| | Pneumonectomy | 1 | 2017 | 167 | 0.450 |
Why?
| | Klippel-Trenaunay-Weber Syndrome | 1 | 2015 | 5 | 0.450 |
Why?
| | Risk Assessment | 10 | 2025 | 3740 | 0.430 |
Why?
| | Registries | 7 | 2025 | 2401 | 0.430 |
Why?
| | Subclavian Artery | 1 | 2014 | 28 | 0.420 |
Why?
| | Perception | 1 | 2017 | 377 | 0.410 |
Why?
| | Catheterization | 2 | 2012 | 183 | 0.410 |
Why?
| | Tissue and Organ Harvesting | 1 | 2014 | 78 | 0.410 |
Why?
| | Arterial Occlusive Diseases | 1 | 2014 | 90 | 0.400 |
Why?
| | Infarction | 1 | 2013 | 9 | 0.400 |
Why?
| | Endarterectomy | 2 | 2012 | 5 | 0.400 |
Why?
| | Cardiovascular Agents | 1 | 2015 | 166 | 0.390 |
Why?
| | Renal Artery | 1 | 2013 | 43 | 0.390 |
Why?
| | Brachiocephalic Trunk | 1 | 2012 | 11 | 0.380 |
Why?
| | Adult | 25 | 2026 | 40665 | 0.380 |
Why?
| | Intraoperative Complications | 1 | 2014 | 157 | 0.380 |
Why?
| | Catheter Obstruction | 1 | 2012 | 4 | 0.380 |
Why?
| | Phlebography | 5 | 2021 | 41 | 0.370 |
Why?
| | Device Removal | 4 | 2024 | 142 | 0.370 |
Why?
| | Vascular Access Devices | 1 | 2012 | 30 | 0.360 |
Why?
| | Mechanical Thrombolysis | 1 | 2012 | 5 | 0.360 |
Why?
| | Ureteral Diseases | 1 | 2012 | 4 | 0.360 |
Why?
| | Urinary Fistula | 1 | 2012 | 9 | 0.360 |
Why?
| | Catheters, Indwelling | 1 | 2012 | 96 | 0.360 |
Why?
| | Health Services Accessibility | 1 | 2020 | 1099 | 0.350 |
Why?
| | Fibrin Tissue Adhesive | 1 | 2012 | 20 | 0.350 |
Why?
| | Vascular Fistula | 1 | 2012 | 22 | 0.350 |
Why?
| | Time-to-Treatment | 3 | 2026 | 250 | 0.350 |
Why?
| | Endoscopy | 1 | 2014 | 317 | 0.350 |
Why?
| | Aneurysm, False | 1 | 2012 | 46 | 0.340 |
Why?
| | Lung Neoplasms | 2 | 2017 | 2662 | 0.340 |
Why?
| | Thrombin | 1 | 2012 | 172 | 0.330 |
Why?
| | Elective Surgical Procedures | 2 | 2024 | 202 | 0.330 |
Why?
| | Catheterization, Central Venous | 1 | 2012 | 123 | 0.330 |
Why?
| | Thrombolytic Therapy | 1 | 2012 | 164 | 0.320 |
Why?
| | Surgical Wound Infection | 2 | 2024 | 329 | 0.310 |
Why?
| | Foreign-Body Migration | 1 | 2010 | 33 | 0.310 |
Why?
| | Exercise Therapy | 1 | 2015 | 475 | 0.310 |
Why?
| | Celiac Artery | 2 | 2025 | 20 | 0.310 |
Why?
| | Length of Stay | 4 | 2024 | 1348 | 0.310 |
Why?
| | Tomography, X-Ray Computed | 7 | 2014 | 2767 | 0.300 |
Why?
| | Limb Salvage | 4 | 2025 | 73 | 0.290 |
Why?
| | Hospital Mortality | 4 | 2024 | 1038 | 0.290 |
Why?
| | New York | 3 | 2014 | 128 | 0.280 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2017 | 1415 | 0.280 |
Why?
| | Evidence-Based Medicine | 5 | 2026 | 739 | 0.280 |
Why?
| | Aortography | 3 | 2014 | 52 | 0.280 |
Why?
| | Cost-Benefit Analysis | 2 | 2025 | 640 | 0.270 |
Why?
| | Regional Blood Flow | 3 | 2017 | 514 | 0.270 |
Why?
| | Constriction, Pathologic | 3 | 2013 | 248 | 0.260 |
Why?
| | Sternum | 2 | 2024 | 27 | 0.250 |
Why?
| | Health Care Surveys | 2 | 2020 | 535 | 0.250 |
Why?
| | Reoperation | 5 | 2019 | 630 | 0.250 |
Why?
| | Sternotomy | 2 | 2024 | 25 | 0.250 |
Why?
| | Endoleak | 2 | 2019 | 17 | 0.240 |
Why?
| | Retroperitoneal Neoplasms | 1 | 2026 | 28 | 0.240 |
Why?
| | Internship and Residency | 3 | 2021 | 1264 | 0.230 |
Why?
| | Aortic Rupture | 2 | 2020 | 27 | 0.230 |
Why?
| | Median Arcuate Ligament Syndrome | 1 | 2025 | 8 | 0.230 |
Why?
| | Ulcer | 1 | 2025 | 37 | 0.230 |
Why?
| | Kidney | 1 | 2013 | 1494 | 0.220 |
Why?
| | Hematoma | 1 | 2025 | 63 | 0.220 |
Why?
| | Injury Severity Score | 3 | 2021 | 599 | 0.220 |
Why?
| | Sclerosing Solutions | 1 | 2024 | 10 | 0.220 |
Why?
| | Kaplan-Meier Estimate | 3 | 2012 | 968 | 0.220 |
Why?
| | Young Adult | 9 | 2025 | 14176 | 0.220 |
Why?
| | Implant Capsular Contracture | 1 | 2024 | 5 | 0.210 |
Why?
| | Renal Nutcracker Syndrome | 1 | 2024 | 8 | 0.210 |
Why?
| | Hematuria | 1 | 2024 | 11 | 0.210 |
Why?
| | Breast Implantation | 1 | 2024 | 21 | 0.210 |
Why?
| | Breast Implants | 1 | 2024 | 31 | 0.210 |
Why?
| | Aortic Diseases | 1 | 2025 | 125 | 0.200 |
Why?
| | Urologic Diseases | 1 | 2024 | 40 | 0.200 |
Why?
| | Stockings, Compression | 2 | 2015 | 5 | 0.200 |
Why?
| | Carcinoma, Renal Cell | 1 | 2026 | 230 | 0.200 |
Why?
| | Predictive Value of Tests | 5 | 2024 | 2115 | 0.200 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2023 | 29 | 0.200 |
Why?
| | Sarcoma | 1 | 2026 | 204 | 0.200 |
Why?
| | Accidents, Traffic | 2 | 2015 | 193 | 0.200 |
Why?
| | Incidence | 5 | 2025 | 2915 | 0.200 |
Why?
| | Down-Regulation | 1 | 2025 | 618 | 0.190 |
Why?
| | C-Reactive Protein | 1 | 2025 | 422 | 0.190 |
Why?
| | Patient Selection | 3 | 2026 | 733 | 0.190 |
Why?
| | Neoplasms | 3 | 2025 | 2900 | 0.190 |
Why?
| | Intracranial Embolism | 1 | 2022 | 34 | 0.190 |
Why?
| | Robotic Surgical Procedures | 1 | 2025 | 183 | 0.190 |
Why?
| | Surgical Flaps | 1 | 2024 | 142 | 0.180 |
Why?
| | Databases, Factual | 3 | 2024 | 1488 | 0.180 |
Why?
| | Health Status Disparities | 1 | 2025 | 320 | 0.180 |
Why?
| | Lymphedema | 1 | 2022 | 22 | 0.180 |
Why?
| | Acute Disease | 4 | 2025 | 1035 | 0.180 |
Why?
| | Angiography | 2 | 2013 | 208 | 0.180 |
Why?
| | Multiple Trauma | 2 | 2021 | 121 | 0.180 |
Why?
| | Administration, Oral | 2 | 2021 | 862 | 0.180 |
Why?
| | Surveys and Questionnaires | 7 | 2022 | 6055 | 0.180 |
Why?
| | Morbidity | 1 | 2023 | 322 | 0.180 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2008 | 1742 | 0.180 |
Why?
| | Off-Label Use | 1 | 2022 | 51 | 0.170 |
Why?
| | Kidney Neoplasms | 1 | 2026 | 412 | 0.170 |
Why?
| | Follow-Up Studies | 4 | 2021 | 5411 | 0.170 |
Why?
| | Varicose Ulcer | 1 | 2021 | 5 | 0.170 |
Why?
| | Mesenteric Arteries | 2 | 2011 | 17 | 0.170 |
Why?
| | Neurosurgery | 1 | 2021 | 41 | 0.170 |
Why?
| | Prognosis | 4 | 2015 | 4310 | 0.170 |
Why?
| | Iliac Vein | 1 | 2021 | 15 | 0.170 |
Why?
| | Abdominal Pain | 2 | 2012 | 149 | 0.160 |
Why?
| | Catheters | 1 | 2021 | 74 | 0.160 |
Why?
| | Prospective Studies | 6 | 2021 | 8035 | 0.160 |
Why?
| | Global Health | 2 | 2020 | 403 | 0.160 |
Why?
| | Brazil | 1 | 2020 | 179 | 0.160 |
Why?
| | Efficiency | 1 | 2021 | 103 | 0.160 |
Why?
| | Ultrasonography, Interventional | 2 | 2012 | 165 | 0.150 |
Why?
| | Puerperal Disorders | 1 | 2020 | 36 | 0.150 |
Why?
| | Pandemics | 4 | 2020 | 1703 | 0.150 |
Why?
| | Certification | 1 | 2021 | 119 | 0.150 |
Why?
| | Arteriovenous Fistula | 1 | 2020 | 38 | 0.150 |
Why?
| | Patient Care Team | 1 | 2025 | 696 | 0.150 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2020 | 85 | 0.150 |
Why?
| | Chronic Disease | 5 | 2024 | 1806 | 0.150 |
Why?
| | United States | 9 | 2025 | 16065 | 0.150 |
Why?
| | Catheterization, Peripheral | 1 | 2021 | 120 | 0.150 |
Why?
| | Patient Acuity | 1 | 2019 | 48 | 0.150 |
Why?
| | Recurrence | 3 | 2012 | 1134 | 0.150 |
Why?
| | Education, Medical, Graduate | 2 | 2021 | 562 | 0.150 |
Why?
| | Cardiology | 1 | 2022 | 360 | 0.140 |
Why?
| | General Surgery | 1 | 2021 | 206 | 0.140 |
Why?
| | Delphi Technique | 3 | 2025 | 330 | 0.140 |
Why?
| | Educational Measurement | 1 | 2021 | 324 | 0.130 |
Why?
| | Clinical Decision-Making | 2 | 2021 | 362 | 0.130 |
Why?
| | Disease Progression | 1 | 2025 | 2857 | 0.130 |
Why?
| | Disease Management | 1 | 2021 | 651 | 0.130 |
Why?
| | Ligation | 1 | 2017 | 91 | 0.130 |
Why?
| | Military Personnel | 1 | 2025 | 736 | 0.120 |
Why?
| | Consensus | 3 | 2026 | 478 | 0.120 |
Why?
| | Thrombosis | 1 | 2020 | 401 | 0.120 |
Why?
| | Clinical Competence | 3 | 2021 | 1240 | 0.120 |
Why?
| | Postoperative Hemorrhage | 1 | 2017 | 105 | 0.120 |
Why?
| | Stroke | 1 | 2024 | 1270 | 0.110 |
Why?
| | Brain Injuries, Traumatic | 1 | 2021 | 453 | 0.110 |
Why?
| | Motorcycles | 1 | 2014 | 7 | 0.110 |
Why?
| | Adaptation, Psychological | 1 | 2020 | 715 | 0.110 |
Why?
| | Ankle Brachial Index | 1 | 2015 | 41 | 0.110 |
Why?
| | Obesity, Morbid | 1 | 2019 | 289 | 0.110 |
Why?
| | Pedestrians | 1 | 2014 | 9 | 0.110 |
Why?
| | Cross-Sectional Studies | 3 | 2020 | 5886 | 0.110 |
Why?
| | Severity of Illness Index | 2 | 2013 | 2928 | 0.100 |
Why?
| | Biomarkers | 1 | 2025 | 4282 | 0.100 |
Why?
| | Multidetector Computed Tomography | 1 | 2013 | 40 | 0.100 |
Why?
| | Minnesota | 1 | 2013 | 168 | 0.090 |
Why?
| | Exercise Tolerance | 1 | 2015 | 283 | 0.090 |
Why?
| | Ovary | 1 | 2014 | 231 | 0.090 |
Why?
| | Duodenoscopy | 1 | 2012 | 8 | 0.090 |
Why?
| | Gastroscopy | 1 | 2012 | 18 | 0.090 |
Why?
| | Matrix Metalloproteinases | 1 | 2013 | 95 | 0.090 |
Why?
| | MEDLINE | 1 | 2012 | 20 | 0.090 |
Why?
| | Injections, Intralesional | 1 | 2012 | 35 | 0.090 |
Why?
| | Cystoscopy | 1 | 2012 | 21 | 0.090 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2012 | 37 | 0.090 |
Why?
| | Debridement | 1 | 2012 | 85 | 0.090 |
Why?
| | Stress, Psychological | 1 | 2020 | 1145 | 0.090 |
Why?
| | Adolescent | 5 | 2025 | 22479 | 0.090 |
Why?
| | Combined Modality Therapy | 1 | 2015 | 1264 | 0.090 |
Why?
| | Carotid Artery, Common | 1 | 2011 | 31 | 0.090 |
Why?
| | Hospitalization | 1 | 2022 | 2458 | 0.090 |
Why?
| | Echinococcosis | 1 | 2011 | 9 | 0.080 |
Why?
| | Fibrinolysis | 1 | 2013 | 164 | 0.080 |
Why?
| | Pilot Projects | 1 | 2017 | 1889 | 0.080 |
Why?
| | Mesenteric Ischemia | 1 | 2010 | 2 | 0.080 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 427 | 0.080 |
Why?
| | Warfarin | 1 | 2022 | 179 | 0.080 |
Why?
| | Recovery of Function | 1 | 2015 | 715 | 0.080 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2011 | 138 | 0.080 |
Why?
| | Coronary Artery Bypass | 1 | 2012 | 268 | 0.080 |
Why?
| | Dog Diseases | 1 | 2011 | 70 | 0.080 |
Why?
| | Embolization, Therapeutic | 1 | 2012 | 242 | 0.080 |
Why?
| | Linear Models | 1 | 2012 | 844 | 0.080 |
Why?
| | Walking | 1 | 2015 | 542 | 0.080 |
Why?
| | Comparative Effectiveness Research | 1 | 2010 | 167 | 0.070 |
Why?
| | Glomerular Filtration Rate | 1 | 2013 | 765 | 0.070 |
Why?
| | Chi-Square Distribution | 1 | 2010 | 527 | 0.070 |
Why?
| | Secondary Prevention | 1 | 2011 | 251 | 0.070 |
Why?
| | Mesentery | 1 | 2009 | 44 | 0.070 |
Why?
| | Animals | 3 | 2025 | 37952 | 0.070 |
Why?
| | Radiography, Interventional | 1 | 2010 | 128 | 0.070 |
Why?
| | Multivariate Analysis | 1 | 2012 | 1546 | 0.070 |
Why?
| | Attitude of Health Personnel | 1 | 2017 | 1186 | 0.070 |
Why?
| | Recombinant Proteins | 1 | 2012 | 1368 | 0.070 |
Why?
| | Child | 3 | 2021 | 22670 | 0.060 |
Why?
| | Logistic Models | 1 | 2012 | 2133 | 0.060 |
Why?
| | Age Factors | 1 | 2014 | 3338 | 0.060 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1325 | 0.060 |
Why?
| | Survival Rate | 1 | 2012 | 2087 | 0.060 |
Why?
| | Hemorrhage | 1 | 2022 | 822 | 0.060 |
Why?
| | Cardiac Surgical Procedures | 1 | 2012 | 608 | 0.060 |
Why?
| | Coronary Artery Disease | 1 | 2012 | 747 | 0.060 |
Why?
| | Hemodynamics | 2 | 2021 | 1115 | 0.060 |
Why?
| | United States Department of Defense | 1 | 2025 | 23 | 0.050 |
Why?
| | Operative Time | 1 | 2025 | 181 | 0.050 |
Why?
| | Silicone Gels | 1 | 2024 | 5 | 0.050 |
Why?
| | Renal Veins | 1 | 2024 | 18 | 0.050 |
Why?
| | Pectoralis Muscles | 1 | 2024 | 18 | 0.050 |
Why?
| | Surgical Wound Dehiscence | 1 | 2023 | 22 | 0.050 |
Why?
| | Neoplasm Invasiveness | 1 | 2025 | 506 | 0.050 |
Why?
| | Quality of Life | 1 | 2015 | 3194 | 0.050 |
Why?
| | Research Design | 1 | 2008 | 1132 | 0.040 |
Why?
| | Mammaplasty | 1 | 2024 | 141 | 0.040 |
Why?
| | Test Taking Skills | 1 | 2021 | 5 | 0.040 |
Why?
| | Plastics | 1 | 2021 | 49 | 0.040 |
Why?
| | Cohort Studies | 1 | 2012 | 5988 | 0.040 |
Why?
| | Administration, Topical | 1 | 2021 | 153 | 0.040 |
Why?
| | Verbal Behavior | 1 | 2021 | 42 | 0.040 |
Why?
| | Wound Healing | 1 | 2023 | 354 | 0.040 |
Why?
| | Personal Protective Equipment | 1 | 2020 | 57 | 0.040 |
Why?
| | Specialties, Surgical | 1 | 2020 | 82 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 2099 | 0.040 |
Why?
| | Signal Transduction | 1 | 2013 | 5208 | 0.040 |
Why?
| | Factor Xa Inhibitors | 1 | 2021 | 194 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2021 | 419 | 0.040 |
Why?
| | Educational Status | 1 | 2021 | 465 | 0.040 |
Why?
| | Workload | 1 | 2020 | 168 | 0.040 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2020 | 529 | 0.030 |
Why?
| | Treatment Failure | 1 | 2019 | 360 | 0.030 |
Why?
| | Salvage Therapy | 1 | 2019 | 165 | 0.030 |
Why?
| | Hot Temperature | 1 | 2020 | 396 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2021 | 1109 | 0.030 |
Why?
| | Ankle | 1 | 2015 | 63 | 0.030 |
Why?
| | Pressure | 1 | 2015 | 226 | 0.030 |
Why?
| | Asymptomatic Diseases | 1 | 2015 | 103 | 0.030 |
Why?
| | Materials Testing | 1 | 2015 | 345 | 0.030 |
Why?
| | Comorbidity | 1 | 2019 | 1657 | 0.030 |
Why?
| | Sclerosis | 1 | 2013 | 11 | 0.020 |
Why?
| | Wound Infection | 1 | 2012 | 59 | 0.020 |
Why?
| | Antigens, Helminth | 1 | 2011 | 16 | 0.020 |
Why?
| | Sheep Diseases | 1 | 2011 | 9 | 0.020 |
Why?
| | Anthelmintics | 1 | 2011 | 12 | 0.020 |
Why?
| | Italy | 1 | 2011 | 114 | 0.020 |
Why?
| | Rabbits | 1 | 2011 | 652 | 0.020 |
Why?
| | Spinal Cord Ischemia | 1 | 2010 | 60 | 0.020 |
Why?
| | Dogs | 1 | 2011 | 438 | 0.020 |
Why?
| | Magnetic Resonance Angiography | 1 | 2011 | 250 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 847 | 0.020 |
Why?
| | Sheep | 1 | 2011 | 876 | 0.020 |
Why?
| | Data Collection | 1 | 2011 | 639 | 0.020 |
Why?
| | Feces | 1 | 2011 | 494 | 0.020 |
Why?
| | Pregnancy | 1 | 2020 | 7182 | 0.020 |
Why?
| | Prevalence | 1 | 2013 | 2855 | 0.010 |
Why?
| | Kidney Failure, Chronic | 1 | 2010 | 599 | 0.010 |
Why?
|
|
Malgor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|